Robotic Surgery Will Explode: Buy This Healthcare Stock Before Its 50% Run.

Core Insights - Intuitive Surgical has recently experienced a significant drawdown, but historical trends suggest this may lead to a subsequent bull run for the stock [1][5] - The company is categorized as a growth stock, with a history of substantial sell-offs followed by price rallies [3][5] - Intuitive Surgical is included in the First Trust Nasdaq Artificial Intelligence and Robotics ETF, which could potentially drive its shares up by 50% or more [2] Company Performance - In Q3 2025, Intuitive Surgical installed 427 da Vinci surgical robots, an increase from 329 in Q3 2024, bringing the total to 10,763 robots globally [6] - The company’s revenue from robot sales constitutes approximately 25% of its total income, with the primary revenue driver being the sale of instruments, accessories, and services related to surgical procedures [7] - Surgical procedures utilizing the da Vinci robot increased by 20% year over year in Q3 2025, despite only a 13% increase in the number of systems [8] Technological Integration - The da Vinci surgical robot enhances patient outcomes through less invasive and more precise procedures [10] - Future advancements may allow for remote operation of the robots, enabling high-quality care from distant locations [11] - There is potential for AI to autonomously operate the da Vinci robots, which could significantly increase the number of surgeries performed and the demand for related parts and services [12][13] - While fully autonomous AI surgery is still a long-term prospect, Intuitive Surgical is already integrating AI into its products, indicating its importance for future growth [14]